Tacrolimus salvage in anti-tumor necrosis factor antibody treatment-refractory Crohn's disease

Inflammatory Bowel Diseases

Volumn 19, Issue 6, 2013, Pages 1107-1111

  Gerich, Mark E ^a   Pardi, Darrell S ^b   Bruining, David H ^b   Kammer, Patricia P ^b   Becker, Brenda D ^b   Tremaine, William T ^b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Anti TNF; Crohn's disease; Prograf; Refractory; Tacrolimus

Indexed keywords

ADALIMUMAB; CERTOLIZUMAB PEGOL; INFLIXIMAB; MERCAPTOPURINE; METHOTREXATE; NATALIZUMAB; TACROLIMUS;

ABDOMINAL PAIN; ADULT; ARTICLE; CLINICAL ARTICLE; CROHN DISEASE; ENTERITIS; FEMALE; FISTULA; FOLLOW UP; HEADACHE; HUMAN; MALE; PARESTHESIA; PRIORITY JOURNAL; RECTUM HEMORRHAGE; REMISSION; TREATMENT DURATION; TREATMENT RESPONSE; TREMOR;

ADMINISTRATION, ORAL; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBODIES, MONOCLONAL; CROHN DISEASE; DRUG RESISTANCE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SALVAGE THERAPY; TACROLIMUS; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84879234714     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0b013e318280b154     Document Type: Article

References (16)

1. Schnitzler F, Fidder H, Ferrante M, et al. Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohort. Gut. 2009;58:492-500.
2. A comparison of tacrolimus (FK 506) and cyclosporine for immunosup-pression in liver transplantation. The U.S. Multicenter FK506 Liver Study Group. N Engl J Med. 1994;331:1110-1115.
3. Jain AB, Venkataramanan R, Cadoff E, et al. Effect of hepatic dysfunction and T tube clamping on FK 506 pharmacokinetics and trough concentrations. Transpl Proc. 1990;22:57-59.
4. Jain A, Venkataramanan R, Todo S, et al. Intravenous, oral pharmacoki-netics, and oral dosing of FK 506 in small bowel transplant patients. Transpl Proc. 1992;24:1181-1182.
5. Sandborn WJ. Preliminary report on the use of oral tacrolimus (FK506) in the treatment of complicated proximal small bowel and fistulizing Crohn's disease. Am J Gastroenterol. 1997;92:876-879.
6. Ierardi E, Principi M, Francavilla R, et al. Oral tacrolimus long-term therapy in patients with Crohn's disease and steroid resistance. Aliment Pharmacol Ther. 2001;15:371-377.
7. Baumgart DC, Wiedenmann B, Dignass AU. Rescue therapy with tacro-limus is effective in patients with severe and refractory inflammatory bowel disease. Aliment Pharmacol Ther. 2003;17:1273-1281.
8. Baumgart DC, Pintoffl JP, Sturm A, et al. Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease - a long-term follow-up. Am J Gastroenterol. 2006;101:1048-1056.
9. Ng SC, Arebi N, Kamm MA. Medium-term results of oral tacrolimus treatment in refractory inflammatory bowel disease. Inflamm Bowel Dis. 2007;13:129-134.
10. Benson A, Barrett T, Sparberg M, et al. Efficacy and safety of tacrolimus in refractory ulcerative colitis and Crohn's disease: a single-center experience. Inflamm Bowel Dis. 2008;14:7-12.
11. Tamaki H, Nakase H, Matsuura M, et al. The effect of tacrolimus (FK-506) on Japanese patients with refractory Crohn's disease. J Gastroenterol 2008;43:774-779.
12. Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55:749-753.
13. Sandborn WJ, Present DH, Isaacs KL, et al. Tacrolimus for the treatment of fistulas in patients with Crohn's disease: a randomized, placebo-controlled trial. Gastroenterology. 2003;125:380-388.
14. Gonzalez-Lama Y, Abreu L, Vera MI, et al. Long-term oral tacrolimus therapy in refractory to infliximab fistulizing Crohn's disease: a pilot study. Inflamm Bowel Dis. 2005;11:8-15.
15. McSharry K, Dalzell AM, Leiper K, et al. Systematic review: the role of tacrolimus in the management of Crohn's disease. Aliment Pharmacol Ther. 2011;34:1282-1294.
16. Lowry PW, Weaver AL, Tremaine WJ, et al. Combination therapy with oral tacrolimus (FK506) and azathioprine or 6-mercaptopurine for treatment-refractory Crohn's disease perianal fistulae. Inflamm Bowel Dis. 1999;5: 239-245.